7 Pulmonary Hypertension Headlines You Can’t Miss
This article unveils some advice for patients with pulmonary hypertension who would like to exercise. Check out the list to discover nine tips for exercising with pulmonary hypertension.
This article is focused on some common signs of pulmonary hypertension. To discover eight common sign of pulmonary hypertension, check out this list.
Women with pulmonary arterial hypertension (PAH) are often sedentary, and the lack of daily activity results in physical and mental feelings of low energy, according to a study published in the journal Chest. The study, “Physical Activity and Symptoms in Pulmonary Arterial Hypertension,” suggested that interventions to improve fatigue and other symptoms may lead to increased physical activity in PAH patients.
The cardiac hormone known as atrial natriuretic peptide (ANP), controls blood pressure both throughout the body and in the lungs. Researchers previously believed that ANP’s hypotensive effect in the lungs was mediated by changes in the smooth muscle that lines pulmonary blood vessels. But scientists now report that the hormone facilitates low blood pressure via the endothelial cells lining the blood vessels.
Actelion has announced that its orally active pulmonary arterial hypertension (PAH) drug, Uptravi (selexipag), has been approved for the treatment of PAH patients by both the Therapeutic Goods Administration of Australia and the New Zealand Medicines and Medical Devices Safety Authority.
Galectin-3 (Gal-3) and the hormone aldosterone are two potential biomarkers for disease progression in patients with pulmonary arterial hypertension, according to a recent study, “Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension,” published in the journal Heart.